Navigation Links
International liver cancer congress provides possible solutions to reduce significant burden
Date:6/25/2010

Geneva, Switzerland, Friday, 25 June 2010: Today, world renowned experts have assembled in Dubrovnik, Croatia to discuss the latest trends in treatment and cutting edge research in diagnostic techniques that will shape the future management of hepatocellular carcinoma (HCC) the third most common cause of cancer-related death globally, and a leading cause of death among patients with liver cirrhosis.

"This HCC conference is a significant milestone in the field of HCC research. We are encouraged by the range of topics and eminent researchers in attendance, bringing new understanding and celebrating new research opportunities from across the world that will help address the current challenges we face as clinicians. This ultimately will help drive our ultimate goal of reducing the suffering caused by this devastating and debilitating disease," commented Professor Josep M Llovet, chair of the HCC special conference and Professor of Research, Liver Unit, Hospital Clnic, Barcelona, Spain and Professor of Medicine, Director, Mount Sinai Liver Cancer Research Program, Mount Sinai School of Medicine, New York.

At the two-day conference, entitled: Hepatocellular Carcinoma from genomics to treatment, organised by the European Association for the Study of the Liver (EASL), experts will address a range of key topics, including: the genetic make-up of HCC, the molecular signatures and biomarkers and other advancements to determine diagnosis and prognosis of HCC, and potential disease targets to develop new treatment strategies. Specifically, several novel molecular targeted therapies are currently being tested in advanced stages of clinical research, and their results expected by 2011-14 might improve the standard of care of patients suffering this neoplasm.

HCC is a cancer originating in liver cells and is one of the most common types of tumour. Worldwide, HCC accounts for approximately 5.4% of all cancers3 and causes 610,000 deaths per year. It is the fifth most common cause of cancer in men and the eighth most common cause in women. HCC is the most common cancer in Sub-Saharan Africa and Southeast Asia mainly due to the high rates of HCV and HBV infection. In western countries, alcoholism and viral hepatitis are the leading causes of cirrhosis and subsequent HCC.

The HCC conference is supported by leading professional organisations across the world, including the American Association for the Study of Liver Diseases (AASLD), the Asian Pacific Association for Study of the Liver (APASL) and the Latin-American for the Study of the Liver (ALEH).

"EASL is dedicated to promoting research and education in the field of hepatology to improve the treatment of liver disease throughout the world. In bringing experts together at this first-ever medical conference on HCC we aim to promote the latest evidence base and best practise to address this significant global killer disease," added Professor Heiner Wedemeyer, EASL Secretary General.

In line with the importance of the meeting, EASL would like to inform its members and the conference delegates that the European Commission Seventh Framework Programme (FP7-Health 2010) has funded the HEPTROMIC project, a 3-year translational research initiative on liver cancer. This network, aimed at solving molecular and technological challenges, constitutes the first European research project specifically focused on genomics in HCC funded by the European Union. With the final negotiations with the European Commission well underway, HEPTROMIC is currently gearing up to become a decisive modern cooperative and multidisciplinary effort in the fight against this cancer. Led from the Institut d'Investigacions Biomdiques August Pi i Sunyer (IDIBAPS) - Hospital Clnic of Barcelona (Spain), this initiative combines the knowhow of six leading research groups in Europe and the USA and two companies, to ensure the translation of research results into new prognostic tests and devices.


'/>"/>

Contact: Isabelle Scali
media.easl2010@cohnwolfe.com
44-771-743-5103
European Association for the Study of the Liver
Source:Eurekalert

Related medicine news :

1. Royal Caribbean International and LimoRes.com Announce Exclusive Partnership
2. Global Aids Alliance Celebrates the Introduction of the International Violence Against Women Act, Urges Swift Passage
3. International Pelvic Floor Muscle Expert Presents Live Webinars on Telemedecine
4. Ganeden Biotech and Pathway International Announce Exclusive Distribution Partnership
5. Luis Tiant and Sunridge International Partner to Provide Medical Relief in Cuba: Former Star Pitcher for the Red Sox and Yankees Leads the Fight Against Glaucoma
6. Rapport International Announces Partnership with SDL
7. MAP International Provides $10 Million in Essential Medicines and Medical Supplies to Haiti Relief
8. Sanford Heart Hospital Physicians Again Recognized Internationally for Innovative Techniques
9. Chances For Children Founder Craig Juntunen Urges International Adoption as Part of the Solution in Aftermath of Haiti Earthquake
10. International Breast Milk Project Delivers Donor Breast Milk to Orphaned and Sick Babies in Haiti
11. AMD Alliance International Announces $10,000 Video Contest
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/24/2016)... Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... surgery procedures that most people are unfamiliar with. The article goes on to state ... procedures, but also many of these less common operations such as calf and cheek ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Marcy was in a crisis. Her son James, ... out at his family verbally and physically. , “When something upset him, he couldn’t control ... use it. He would throw rocks at my other children and say he was going ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda ... orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including ... accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening ... Talker Award, an essay contest in which patients and their families pay tribute to ... at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Bracket , ... launch its next generation clinical outcomes platform, Bracket eCOA (SM) ... held on June 26 – 30, 2016 in ... first electronic Clinical Outcome Assessment product of its kind to ... #715. Bracket eCOA 6.0 is a flexible platform ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 ... Tomorrow,s Leaders Scholarship is any indication, the future is ... online at www.diabetesscholars.org by the Diabetes Scholars ... in the way of academic and community service excellence. ... program since 2012, and continues to advocate for people ...
(Date:6/23/2016)... 2016 Revolutionary technology includes multi-speaker ... , industry leaders in advanced audiology and hearing aid ... Opn ™, the world,s first internet connected hearing aid ... devices.      (Photo: http://photos.prnewswire.com/prnh/20160622/382240 ) ... of ,world firsts,: , TwinLink™ - the ...
Breaking Medicine Technology: